A. Zervoudaki

498 total citations
13 papers, 400 citations indexed

About

A. Zervoudaki is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, A. Zervoudaki has authored 13 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Pharmacology. Recurrent topics in A. Zervoudaki's work include Blood Pressure and Hypertension Studies (7 papers), Cardiovascular Health and Disease Prevention (5 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). A. Zervoudaki is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Cardiovascular Health and Disease Prevention (5 papers) and Cerebrovascular and Carotid Artery Diseases (3 papers). A. Zervoudaki collaborates with scholars based in Greece, Switzerland and France. A. Zervoudaki's co-authors include Christodoulos Stefanadis, P Pietri, Gregory P. Vyssoulis, Konstantinos Aznaouridis, Charalambos Vlachopoulos, T. Gialernios, Pavlos Toutouzas, Marina Toutouza, E. N. Economou and C. Aggeli and has published in prestigious journals such as Osteoporosis International, Journal of Hypertension and European Journal of Clinical Nutrition.

In The Last Decade

A. Zervoudaki

13 papers receiving 393 citations

Peers

A. Zervoudaki

CCM

PRM

EDM

SURGE

Pawan Pusalkar United Kingdom

Toshiyuki Niki Japan

Foo Leong Li‐Saw‐Hee United Kingdom

Filippo Scalise Italy

Pingshuan Dong China

A BLANN United Kingdom

Koen Verdonk Netherlands

Litong Qi China

Jason L. Guichard United States

Hafid Narayan United Kingdom

Pawan Pusalkar United Kingdom

A. Zervoudaki

243 ×1.1

CCM

109 ×1.3

99 ×1.5

PRM

38 ×0.7

EDM

58 ×1.1

SURGE

Citations per year, relative to A. Zervoudaki A. Zervoudaki (= 1×) peers Pawan Pusalkar

Countries citing papers authored by A. Zervoudaki

Since Specialization

Citations

This map shows the geographic impact of A. Zervoudaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Zervoudaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Zervoudaki more than expected).

Fields of papers citing papers by A. Zervoudaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Zervoudaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Zervoudaki. The network helps show where A. Zervoudaki may publish in the future.

Co-authorship network of co-authors of A. Zervoudaki

This figure shows the co-authorship network connecting the top 25 collaborators of A. Zervoudaki. A scholar is included among the top collaborators of A. Zervoudaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Zervoudaki. A. Zervoudaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Beaudet, Amélie, et al.. (2017). Cost-Effectiveness Of Selexipag For The Treatment Of Pulmonary Arterial Hypertension (PAH) In Greece. Value in Health. 20(9). A645–A645. 4 indexed citations

Bilir, S. Pinar, et al.. (2017). Budget-Impact of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Greece. Value in Health. 20(9). A641–A642. 1 indexed citations

Watfa, Ghassan, Athanase Bénétos, Anna Kearney‐Schwartz, et al.. (2015). Do Arterial Hemodynamic Parameters Predict Cognitive Decline Over a Period of 2 Years in Individuals Older Than 80 Years Living in Nursing Homes? The PARTAGE Study. Journal of the American Medical Directors Association. 16(7). 598–602. 17 indexed citations

Bénétos, Athanase, A. Zervoudaki, Anna Kearney‐Schwartz, et al.. (2008). Effects of lean and fat mass on bone mineral density and arterial stiffness in elderly men. Osteoporosis International. 20(8). 1385–1391. 29 indexed citations

Vlachopoulos, Charalambos, Konstantinos Aznaouridis, Ioanna Dima, et al.. (2007). Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults. International Journal of Cardiology. 122(3). 232–238. 30 indexed citations

Aznaouridis, Konstantinos, Gregory P. Vyssoulis, Eva A. Karpanou, et al.. (2007). Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment. Blood Pressure Monitoring. 12(2). 87–94. 2 indexed citations

Pietri, P, Gregory P. Vyssoulis, Charalambos Vlachopoulos, et al.. (2006). Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. Journal of Hypertension. 24(11). 2231–2238. 92 indexed citations

Vlachopoulos, C., Nikolaos Alexopoulos, A. Zervoudaki, et al.. (2006). Effect of chronic coffee consumption on aortic stiffness and wave reflections in hypertensive patients. European Journal of Clinical Nutrition. 61(6). 796–802. 18 indexed citations

Vyssoulis, Gregory P., Eva A. Karpanou, Dionysios Adamopoulos, et al.. (2006). Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial.. PubMed. 47(1). 21–8. 40 indexed citations

10.

Tsioufis, Costas, Elena Vezali, Kyriakos Dimitriadis, et al.. (2005). The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. Journal of Human Hypertension. 19(3). 211–217. 31 indexed citations

11.

Zervoudaki, A.. (2004). The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension. American Journal of Hypertension. 17(3). 273–276. 41 indexed citations

12.

Zervoudaki, A., E. N. Economou, Christodoulos Stefanadis, et al.. (2003). Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment. Journal of Human Hypertension. 17(2). 119–124. 90 indexed citations

13.

Zervoudaki, A. & Pavlos Toutouzas. (2003). Remodeling of Resistance Vessels in Essential Hypertension. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact